ContraFect Corporation
CFRXQ
$0.0002
$0.000.00%
OTC PK
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 11.74M | 12.30M | 12.46M | 12.15M | 12.92M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 30.21M | 37.72M | 49.77M | 56.89M | 64.27M |
| Operating Income | -30.21M | -37.72M | -49.77M | -56.89M | -64.27M |
| Income Before Tax | -24.14M | -35.85M | -46.37M | -65.15M | -59.71M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -24.14 | -35.85 | -46.37 | -65.15 | -59.71 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -24.14M | -35.85M | -46.37M | -65.15M | -59.71M |
| EBIT | -30.21M | -37.72M | -49.77M | -56.89M | -64.27M |
| EBITDA | -30.06M | -37.56M | -49.61M | -56.74M | -64.11M |
| EPS Basic | -19.28 | -53.49 | -88.35 | -128.65 | -121.46 |
| Normalized Basic EPS | -12.07 | -23.64 | -45.42 | -70.61 | -66.10 |
| EPS Diluted | -19.28 | -53.49 | -88.35 | -128.65 | -121.46 |
| Normalized Diluted EPS | -12.07 | -23.64 | -45.42 | -70.61 | -66.10 |
| Average Basic Shares Outstanding | 17.19M | 6.98M | 3.57M | 2.08M | 1.97M |
| Average Diluted Shares Outstanding | 17.19M | 6.98M | 3.57M | 2.08M | 1.97M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |